Metropolitan Life Insurance Company (MetLife)’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio PTVE Stock Details PTVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,187	Closed	-$31.3K	–	2211
2024 Q1	$31.3K	Sell	2,187 -591	-21%	-$8.38K	﹤0.01%	1644
2023 Q4	$38.1K	Hold	2,778	–	–	﹤0.01%	1599
2023 Q3	$22.6K	Hold	2,778	–	–	﹤0.01%	1829
2023 Q2	$21K	Hold	2,778	–	–	﹤0.01%	1903
2023 Q1	$22.2K	Hold	2,778	–	–	﹤0.01%	1837
2022 Q4	$31.6K	Sell	2,778 -891	-24%	-$9.72K	﹤0.01%	1760
2022 Q3	$32K	Hold	3,669	–	–	﹤0.01%	1756
2022 Q2	$36.5K	Hold	3,669	–	–	﹤0.01%	1694
2022 Q1	$36.9K	Sell	3,669 -9,778	-73%	-$104K	﹤0.01%	1763
2021 Q4	$171K	Buy	13,447 +4,340	+48%	+$56.5K	﹤0.01%	2132
2021 Q3	$114K	Sell	9,107 -4,338	-32%	-$58.9K	﹤0.01%	2458
2021 Q2	$203K	Buy	13,445 +2,094	+18%	+$31.4K	﹤0.01%	2129
2021 Q1	$156K	Sell	11,351 -1,073	-9%	-$16.6K	﹤0.01%	2185
2020 Q4	$225K	Buy	+12,424	New	+$192K	﹤0.01%	1855

Other funds holding PTVE

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s PTVE Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2024, closing a stake of 2,187 shares — an estimated $31.3K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in PTVE in Q4 2020 and held it in 14 quarters. The position peaked at $225K in Q4 2020. 142 funds tracked by Wall St. Rank hold PTVE as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 2,187 Pactiv Evergreen Inc. Common stock shares in Q2 2024, an estimated $31.3K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Pactiv Evergreen Inc. Common stock in Q4 2020 and held it in 14 quarters.
Metropolitan Life Insurance Company (MetLife)'s Pactiv Evergreen Inc. Common stock position peaked at $225K in Q4 2020.
142 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.